Lower back surgery represents a life-changing decision that demands careful consideration. While many view surgery as a ...

Satellos’ condensed consolidated interim financial statements for the three and nine months ended September 30, 2024, and the related management’s discussion and analysis (MD&A) will be available on ...

Creative Medical Technology (CELZ) announces the successful completion of an independent interim safety review by the Data Safety Monitoring ...

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

FibroBiologics holds 160+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing ...